Health Care: Drugs

Dyax Corporation (DYAX: NASDAQ)

$1.87 0.07 | 3.89%
06/04/12 - 09:59 AM ET
Company Profile
Price and Volume
Recent Price 1.80
52 Week High 2.17
52 Week Low 1.10
Avg. Daily Vol. (Mil) 0.24
Beta (3 year) 1.66
Share Related Items
Mkt Cap (Mil) 177.84
Shares Out (Mil) 98.80
Float (Mil) 77.73
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.50
Current Ratio 3.10
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 3.42
Price/Book 0.00
Price/Cash Flow -5.40
Per Share Data
Earnings -0.35
Sales 0.53
Book Value 0.00
Cash Flow -0.33
Business Summary
Dyax Corporation is a biotechnology company, which is engaged in the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications.
General Information
300 Technology Square
Cambridge, MA 02139
www.dyax.com
Industry : Drugs
Sector: Health Care
Employees: 120
CEO: Gustav A. Christensen
Short Interest
Current Month (Mil) 4.24
Previous Month (Mil) 4.25
Short Interest Ratio (Days) 22.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -50.90
Return on Investments -92.00
Profitability
Gross Margin n.a.
EBIT Margin -46.90
Profit Margin -66.60

Portfolios with DYAX

Latest DYAX Headlines from TheStreet

More Financial News for DYAX

Press Releases for DYAX

See All Press Releases

Partner Headlines for DYAX

Get started with stockpickr! Get recommendations from thousands of mutual funds, hedge funds, and others. Enter your favorite stocks now!
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter